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867-4 Acute Administration of Asymmetric Dimethylarginine 
Reduces Insulin Sensitivity in Mice
Ken Y. Lin, John P. Cooke, Stanford University School of Medicine, Stanford, CA
Background: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO
synthase. ADMA is metabolized by dimethylarginine dimethylaminohydrolase (DDAH).
We have shown that plasma ADMA level inversely correlates with a measure of insulin
sensitivity in humans. We now examine if ADMA reduces insulin sensitivity.
Method: After 4hrs of fasting, wildtype female C57BL/6J mice were injected i.p. with
either ADMA (75mg/kg) or PBS; transgenic mice overexpressing DDAH were given the
same dose of ADMA (n=3 in each group). After 2hrs, insulin was injected and blood glu-
cose was assayed every 5min for 1hr. The half-time of glucose disappearance from
plasma was calculated using a first-order decay model. Plasma ADMA was measured by
HPLC.
Result: Wildtype mice given ADMA showed a delayed and attenuated drop in glucose in
response to insulin compared to those receiving PBS (see figure). Wildtype mice given
ADMA had a significantly higher glucose half-life than those given PBS (47.8±8.5 vs.
20.9±0.4min). Transgenic mice were resistant to the effects of ADMA, and their glucose
half-life was not significantly different from wildtype mice receiving PBS. When given
ADMA, wildtype mice had significantly higher plasma ADMA compared to transgenic
mice (9.2±0.7 vs. 2.9±0.7µM).
Conclusion: Elevated plasma ADMA acutely reduces insulin sensitivity in mice. We
speculate that there is a form of physiological insulin resistance, secondary to ADMA-
induced reduction in skeletal muscle blood flow and glucose disposition.
9:30 a.m.
867-5 Rosiglitazone Modulates Angiogenic Progenitor Cell 
Differentiation and Attenuates Intimal Hyperplasia After 
Vascular Intervention
Chao-Hung Wang, Shu-Hong Li, Richard D. Weisel, Paul E. Szmitko, Cristina Fayet, Ren-
Ke Li, William Stanford, Subodh Verma, Toronto General Hospital, Toronto, ON, Canada
PPAR-γ agonists inhibit vascular smooth muscle proliferation and migration, and improve
endothelial function. It is unknown whether PPAR-γ agonists favorably modulate bone
marrow-derived angiogenic progenitor cells (APCs) to promote endothelial lineage differ-
entiation and early reendothelialization following vascular intervention.
Methods & Results: C57/BL6 mice, treated with or without rosiglitazone (8 mg/kg/day),
a PPAR-γ agonist, underwent femoral angioplasty. Rosiglitazone treatment attenuated
neointimal formation (Intima/Media ratio: 0.98 ± 0.12 rosiglitazone vs. 3.1 ± 0.5 control,
p<0.001, n=10 per group). The contribution of bone marrow-derived cells to neointimal
formation was investigated by bone marrow transplantation from eYFP mice to back-
ground mice. 58±12% of the cells within the neointima at 4 weeks were derived from the
bone marrow. Pure endothelial marker-positive, pure α-smooth muscle actin (αSMA)-
positive, or double-positive APCs could be found in both mouse bone marrow and in
human peripheral blood after culture in conditional medium enriched with VEGF. Rosigli-
tazone caused a 6-fold (p<0.001) increase in colony formation by human endothelial pro-
genitor cells, promoted the differentiation of APCs towards the endothelial lineage in
mouse bone marrow in vivo (from 0.66±0.06% in the control group to 0.95±0.08% in the
rosiglitazone group, p<0.05) and in human peripheral blood in vitro (from 17±2% in the
control group to 42±6% in the rosiglitazone group, p<0.05), and inhibited the differentia-
tion towards the smooth muscle cell lineage. Within the neointima, rosiglitazone also
stimulated APCs to differentiate into mature endothelial cells and caused earlier reendot-
helialization compared to controls (31±5 vs. 8±2 CD31-positive cells per mm of neointi-
mal surface on day 14, p<0.01).Conclusion: Progenitor cells in adult bone marrow and
peripheral blood have different cell fates, being able to develop along hematopoietic,
endothelial, & smooth muscle lineages. Rosiglitazone promotes the differentiation of
APCs towards the endothelial lineage, enhances APC homing to injured vascular sites,
and attenuates restenosis after angioplasty
9:45 a.m.
867-6 Versican Promoter Is a Target for the β-Catenin/Tcf-4 
Signaling Pathway in Vascular Smooth Muscle Cells
Maziar Rahmani, Jon Carthy, Jason T. Read, Zongshu Luo, Mitra Esfandiarei, Paul S. 
Rennie, Bruce M. McManus, University of British Columbia, Vancouver, BC, Canada
Background: Versican (VCN) is one of the proteoglycans constitutively expressed in ath-
erosclerotic lesions. We have investigated the role of the signaling pathways and cis- and
trans-factors in VCN regulation in vascular smooth muscle cells (VSMCs).
Methods and Results: A 752-bp of the human VCN promoter was cloned in luciferase
reporter plasmid (VCN-Luc). PI3K inhibitor LY29004 significantly decreased promoter
activity. Co-transfection of constitutive active- and dominant negative-protein kinase B
(PKB) constructs with VCN-Luc increased and decreased VCN promoter activity. Inhibi-
tion of the glycogen synthase kinase-3β (GSK-3β) activity by LiCl augmented accumula-
tion of β-catenin and induction of promoter activity. β-catenin has no DNA binding domain
therefore it cannot induce transcription of VCN alone. Software analysis revealed a Tcf-4
transcription factor binding site in the VCN promoter. Electrophoretic mobility shift assay
and supershift assay revealed specific binding of recombinant hTcf-4 to this site in the
VCN promoter. In addition, GSK3-β inhibitor LiCl or β-catenin expression vector did not
induce promoter activity when the Tcf-4 binding site was mutated.
Conclusions: Our findings suggest that VCN transcription is predominantly mediated by
activation of PKB and subsequent inhibition of GSK-3β pathway via β-catenin/Tcf-4 tran-
scription factor complex in the VCN promoter in VSMCs. Supported by the Canadian
Institutes of Health Research and the St. Paul’s Hospital Foundation. 
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873-2 Enhanced Pressure Wave Reflection Contributes to Left 
Ventricular Diastolic Dysfunction in Hypertension
Giuseppe Talanas, Pietro Sanna, Davide Pittalis, Pier Sergio Saba, Giuseppina Fiore, 
GianFranco Tola, Barbara Tanda, Antonello Ganau, University of Sassari, Sassari, Italy
Background. Hypertensive left ventricular diastolic dysfunction has been attributed to
intrinsic abnormalities of myocardial relaxation and stiffness. Since relaxation is load-
dependent, it can be affected by changes in afterload due to stronger and earlier
reflected arterial pressure waves (RPWs) caused by hypertension-related aortic stiffen-
ing. Our aim was to analyse relationships of both timing and intensity of RPWs with left
ventricular diastolic function in hypertension.
Methods. We studied 98 untreated uncomplicated hypertensives and 72 healthy controls
We measured left ventricular mass index, isovolumic relaxation time (IRT), peak veloci-
ties of early and late filling and their ratio (E/A) by Doppler-echocardiography. Augmenta-
tion index and transit time of RPWs as percent of ventricular ejection (TT/ET) were
measured on carotid pressure waveforms recorded by applanation tonometry. Aortic stiff-
ness was assessed by aortic pulse wave velocity (PWV).
Results. Hypertensives had significantly higher left ventricular mass (+23%), IRT (+8%),
PWV (+30%) and augmentation index (+185%), and lower E/A (-34%) and TT/ET (-17%)
than controls (p<.01 to .0001). Age and systolic blood pressure were both significantly
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related to PWV (r=.59 and .61, respectively), augmentation index (r=.53 and .56) and TT/
ET (r =-.60 and -.55) (all p<.0001). Age was also significantly related to IRT and E/A
(r=.44 and -.68) (both p<.0001), and systolic pressure to IRT (r=.20, p<.05) and E/A (r=-
.42, p<.0001). In the overall population, augmentation index and TT/ET were significantly
related to IRT (r=.25 and -.28, respectively) and E/A (r=-.48 and .51) (p<.001). PWV was
related to IRT and E/A (r=.36 and -.60, both p<.0001). After controlling for PWV, TT/ET
and augmentation index, relationships of blood pressure with diastolic function lost any
significance and those of age with IRT (r=.26, p<.001) and E/A (-.44, p<.0001) became
weaker.
Conclusion. Both aging and hypertension enhance pressure wave reflection by increas-
ing aortic stiffness. Stronger and earlier RPWs affect relaxation and filling and represent
an important functional mechanism of left ventricular diastolic abnormalities.
9:00 a.m.
873-3 Pulse Pressure Is the Best Predictor of Cardiovascular 
Mortality in 12,763 Middle-Aged Men of the Seven 
Countries Study: 25-Year Follow-Up
Demosthenes B. Panagiotakos, Christos Pitsavos, Christina Chrysohoou, Anastasios 
Dontas, Alessandro Menotti, Henry Blackburn, Daan Kromhout, On Behalf of the Seven 
Countries Study Group, University of Athens, Glyfada, Greece
BACKGROUND: Hypertension is a dominant characteristic in the prediction of cardiovas-
cular disease (CVD). However, much attention has been given over the years to which
blood pressure is the best measure for CVD events. The aim of this study was to evaluate
the effect of pulse pressure on CVD mortality.
METHODS: Sixteen cohorts of in total 12,763 men aged 40-59 in seven countries (one
cohort in the USA, two in Finland, one in the Netherlands, three in Italy, two in Croatia
(former Yugoslavia), three in Serbia (former Yugoslavia), two in Greece, two in Japan)
were surveyed from 1958 to 1964. Risk factors and personal characteristics were mea-
sured and follow-up for vital status and causes of death were carried out over 25 years
(1985). Analyses were based on comparisons of mean levels of risk factors and death
rates within the 16 cohorts. RESULTS: The relation of pulse pressure and 25-year CVD
mortality was strongly positive and significant in all cohorts (age adjusted hazard ratio
(HR) varied among cohorts from 1.06 to 1.17 per 5 mm Hg, p < 0.05). Moreover, statisti-
cal analysis (based on Akaikes’ Information Criterion) revealed that pulse pressure levels
were the best predictor for CVD deaths among all blood pressure measurements. This
trend was recognizable in normotensive, borderline and sustained hypertensive men,
where CVD mortality increased with the level of pulse pressure. Pulse pressure levels
were also a significant predictor for coronary heart disease deaths (pooled HR per 5 mm
Hg = 1.10, 95% CI 1.08 to 1.11) as well as stroke (pooled HR per 5 mm Hg = 1.13, 95%
CI 1.12 to 1.17). CONCLUSION: Based on a large, multicultural, population sample of
middle-aged men, we revealed that pulse pressure was the best predictor for CVD mor-
tality, among all arterial blood pressures. A potential explanation is that the increase in
pulse pressure levels represents the decreased distensibility of the systemic arterial sys-
tem, which causes the reflect wave to return during ventricular systole.
9:15 a.m.
873-4 Microalbuminuria Predicts Coronary Microvascular 
Dysfunction in Hypertensive African Americans With 
Left Ventricular Hypertrophy
Jan L. Houghton, Patricia Kuhner, Mikhail Torosoff, Albany Medical College, Albany, NY
Background: Microalbuminuria (MAL), defined as subclinical elevation of albumin in the
urine between 30 to 300 mg/day, is a marker of endothelial dysfunction and, in population
studies, has been shown to be an independent predictor of ischemic heart disease. MAL
is postulated to occur because of increased microvascular permeability which is caused
by circulating inflammatory cytokines or, alternatively, glomerular hypertension. Thus,
MAL may be a useful cardiovascular biomarker. The purpose of our study was to exam-
ine the correlation between MAL and invasive measures of coronary microvascular func-
tion in hypertensive subjects with normal coronary arteries.
Methods: MAL was quantitatively measured in a spot urine collection obtained at the
time of the pre-catheterization clinical evaluation. Normal urine albumin concentration is
defined as < 2 mg/dl and MAL as 2 to 20 mg/dl. Coronary endothelial function was mea-
sured using the Doppler Flowire, quantitative coronary angiography, and the endothe-
lium-dependent and -independent agents, acetylcholine (ACh) and adenosine. The study
examined 46 African American (AA) and 58 white (W) hypertensive subjects of similar
age, MAP, and BMI with left ventricular hypertrophy (LVH), defined as LV mass indexed
by ht2.7 > 47 g/m2.7 in women and > 50 in men.
Results: MAL was present in 19 of 46 AA (41%) and in 14 of 58 W (24%). Both indexed
LV mass and MAL were significantly greater in AA (70 +/- 2.8 vs 63 +/- 2 g/m2.7, p =
0.038, and 3.0 +/- 0.6 vs 1.6 +/- 0.4 mg/dl, p = 0.046). Peak coronary blood flow (CBF)
response to ACh was inversely correlated with MAL concentration among AA (p = 0.03, r
= -0.5) but not among W subjects (p = 0.51, r = -0.19). Similarly, peak CBF response to
adenosine was inversely correlated with MAL among AA (p = 0.015, r = -0.55), but not
among W subjects (p = 0.22, r = -0.35). Finally, peak CBF response to adenosine, but not
ACh, was inversely correlated with MAP among both AA (p = 0.03, r = -0.32) and W sub-
jects (p = 0.01, r = -0.34). This appeared to be related, in part, to interaction between
MAL and MAP.
Conclusion: We conclude that MAL, in combination with MAP, are useful noninvasive
biomarkers for the prediction of coronary microvascular dysfunction, particularly among
AA.
9:30 a.m.
873-5 Systolic Reflective Index: A New Parameter to Study 
Arterial Elasticity
Daniel A. Duprez, Wayne Whitwam, Daniel R. Kaiser, Stanley M. Finkelstein, Stephen P. 
Glasser, Andres Belalcazar, Robert Patterson, Jay N. Cohn, University of Minnesota, 
Minneapolis, MN
Background:
Non-invasive techniques to evaluate arterial stiffness include radial artery pulse contour
analyis. Diastolic pulse contour analysis provides separate assessment of large artery
(C1) and small artery (C2) elasticity. Systolic analysis can identify two pressure peaks
(P1 and P2) that relate to incident and reflected waves.
Objective:
To evaluate the relationship between systolic reflective index (SRI, defined as the ratio
P2/P1) from systolic pulse contour analysis and C1 and C2, derived from diastolic pulse
contour analysis in asymptomatic individuals screened for cardiovascular disease.
Methods:
In 320 subjects (220 male and 100 female healthy subjects with a mean age
51 ± 12 years) radial pulse contour analysis was performed with a piezoelectric trans-
ducer and the CVProfilor-D2020.
Results:
The SRI averaged 0.918 ± 0.059, C1 16.70 ± 5.80 ml/mm Hg x 10 and C2
6.49 ± 3.21 ml/mm Hg x 100. SRI was inversely related to C2 (r = -0.590,
P<0.001) and to C1 (r = -0.285, P<0.001). SRI positively related to age
(r = 0.427, P<0.001) and negatively to height (r = -0.220, P<0.001) and weight (r = -
0.177, P<0.001). There was a weak relationship between SRI and systolic (r = 0.230,
P<0.001) and diastolic blood pressure (r = 0.130,
P<0.001), while there was no relationship with heart rate.
Conclusions:
Systolic Reflective Index (SRI) derived from the systolic part of the radial pulse contour
analysis is a useful parameter in the non-invasive assessement of arterial stiffness,
which is more influenced by small than large artery elasticity. Diastolic pulse contour
analysis provides more insight by separate assessment of the large and small artery
elasticity.
9:45 a.m.
873-6 Disparate Effects of Aging on Indices of Aortic Stiffness 
and Wave Reflection
Audrey Adji, Michael O'Rourke, St. Vincent's Clinic, UNSW, Sydney, Australia
Background:
Multiple studies in normal subjects have shown progressive increase in aortic pulse wave
velocity (AoPWV) with age, indicating aortic degeneration and stiffening. Such increase
is accentuated in patients with hypertension and ischemic heart disease. Studies have
also shown increase in late systolic augmentation (AIx) of radial, carotid and aortic pres-
sure waveforms with age. In contrast, preliminary Framingham data, while confirming
age increase in AoPWV, shows little increase in carotid AIx with age.
Method:
This study was conducted to explain apparently anomalous findings. A clinical cardiology
practice database was interrogated (460 patients, 18-92 years), who were screened for
cardiovascular disease or treated for established disease, predominantly atherosclerotic
or hypertensive. The vast majority were receiving antihypertensive, vasodilator or anti-
anginal therapy. Aortic AIx was determined indirectly using SphygmoCor® from the radial
pulse.
Result:
The study population showed less increase in AIx with age (AIx=0.27(age)+8.8), than an
untreated group (AIx=0.74(age)-17.1; Wilkinson et al. Hypertension 2001;38:1461-6) in
whom the same technique was used. Thus findings are similar to Framingham, where
persons with blood pressure >=140 mmHg were commonly treated with vasodilator
drugs, which reduce wave reflection, while having little or no direct effect on aortic stiff-
ness.
Conclusion:
In populations with hypertensive and atherosclerotic disease, increase in aortic stiffness
with age can be gauged by AoPWV, but not by AIx, since AIx is modified by drug therapy.
